| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $46,394,015 ) (Continued on the next page) |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01CA263986 | Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients | 002 | 3 | NIH | 12/11/2023 | $344,507 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AR080203 | Multi-omic Studies of Local and Systemic Immune Dysregulation in Rosacea | 001 | 2 | NIH | 4/11/2024 | -$169,883 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AR080203 | Multi-omic Studies of Local and Systemic Immune Dysregulation in Rosacea | 000 | 2 | NIH | 1/29/2024 | $169,884 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99DK134853 | Competing effects of AgRP and POMC neurons on cAMP signaling in downstream neurons in vivo | 000 | 2 | NIH | 1/24/2024 | $90,000 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK134806 | Investigating the regulation of distinct human adipocyte subpopulations | 000 | 2 | NIH | 11/2/2023 | $150,736 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21MH133001 | Identification of Distinct Biotypes in Clinical High Risk for Psychosis State Using Objective Brain-Based Biomarkers | 000 | 2 | NIH | 1/12/2024 | $139,687 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MD016068 | Effects of DASH Groceries on Blood Pressure in Black Residents of Urban Food Deserts | 000 | 3 | NIH | 2/14/2024 | $764,599 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL160003 | Long-Term Endothelial Effects of COVID-19 in Obesity | 000 | 3 | NIH | 2/29/2024 | $608,959 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08DK132413 | Lymphatic-adipocyte interactions in obesity and lymphedema | 000 | 3 | NIH | 3/28/2024 | $164,484 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS122589 | Neuronal Circuit Controlling Sleep-Promoting Ventrolateral Preoptic Neurons | 001 | 3 | NIH | 4/9/2024 | $26,242 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS122589 | Neuronal Circuit Controlling Sleep-Promoting Ventrolateral Preoptic Neurons | 000 | 3 | NIH | 1/17/2024 | $337,389 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK128406 | The role of interferon regulatory factors in tanycytes during HFD-induced inflammation, obesity and glucose dysregulation | 000 | 3 | NIH | 3/13/2024 | $491,059 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL163172 | Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity | 000 | 3 | NIH | 4/1/2024 | $581,874 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL161385 | Using Machine Learning to find a life saving needle in a haystack of children's emergencies | 002 | 3 | NIH | 2/13/2024 | $537,996 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 000 | 3 | NIH | 12/12/2023 | $342,342 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK133948 | CalR: A toolkit and repository for experiments of energy homeostasis using indirect calorimetry | 000 | 3 | NIH | 1/24/2024 | $389,025 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3?UTR somatic mutations controlling tumor immune evasion | 001 | 3 | NIH | 4/17/2024 | $28,465 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3?UTR somatic mutations controlling tumor immune evasion | 000 | 3 | NIH | 1/23/2024 | $512,353 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08HL161259 | Regulation of endothelial cell phosphatidylserine in thrombosis | 000 | 3 | NIH | 12/15/2023 | $165,024 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258442 | Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma | 001 | 3 | NIH | 4/17/2024 | $21,229 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258442 | Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma | 000 | 3 | NIH | 12/18/2023 | $352,940 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 4 | NIH | 4/24/2024 | $166,667 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 4 | NIH | 4/24/2024 | $208,333 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 4 | NIH | 4/24/2024 | $125,000 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 4 | NIH | 4/24/2024 | $3,556,388 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 4 | NIH | 4/24/2024 | $166,667 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 4 | NIH | 4/24/2024 | $200,000 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA262629 | Personalized Adoptive T-cell Therapy for AML | 001 | 3 | NIH | 4/17/2024 | $36,426 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA262629 | Personalized Adoptive T-cell Therapy for AML | 000 | 3 | NIH | 12/15/2023 | $655,651 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MH123431 | Roles of cortical neuromodulation and offline reactivation in memory consolidation of emotionally salient visual experiences | 000 | 4 | NIH | 4/24/2024 | $350,000 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG068141 | The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) Study | 000 | 4 | NIH | 4/19/2024 | $670,235 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR019628 | Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention | 000 | 4 | NIH | 12/21/2023 | $461,292 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K24AG071906 | Research and mentoring program in shared decision making in the care of older adults | 000 | 4 | NIH | 4/1/2024 | $188,874 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AT011043 | Understanding components of mind-body exercise for physical activity engagement in metabolic syndrome | 000 | 4 | NIH | 1/17/2024 | $162,680 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK125846 | Characterizing the role of the heme catabolism in tissue damage and inflammation. | 000 | 4 | NIH | 2/19/2024 | $471,245 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL157530 | A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events | 000 | 4 | NIH | 3/27/2024 | $403,673 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL155717 | Myocardial Radiomics and Mechanics in the Pathology and Prognosis of Cardiovascular Disease | 000 | 4 | NIH | 3/28/2024 | $756,218 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23MH122701 | Retinal Layer, Microvascular and Electroretinographic Determinants of Early Course Schizophrenia | 000 | 4 | NIH | 4/17/2024 | $192,024 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23ES035863 | Climate Variability and Respiratory Health in Asthma and COPD | 000 | 1 | NIH | 3/27/2024 | $256,202 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P30HS029762 | Massachusetts Institute for Equity-Focused Learning Health System Science (MIELHSS) | 001 | 1 | AHRQ | 1/10/2024 | $999,286 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P30HS029762 | Massachusetts Institute for Equity-Focused Learning Health System Science (MIELHSS) | 001 | 1 | AHRQ | 1/10/2024 | -$999,286 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P30HS029762 | Massachusetts Institute for Equity-Focused Learning Health System Science (MIELHSS) | 000 | 1 | AHRQ | 12/27/2023 | $999,286 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI179405 | Lupus nephritis: novel insights in the pathogenesis and treatment | 000 | 1 | NIH | 3/1/2024 | $2,247,493 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI179405 | Lupus nephritis: novel insights in the pathogenesis and treatment | 001 | 1 | NIH | 3/12/2024 | $18,225 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA276107 | Control of cancer cachexia via stimulation of resolution of inflammation | 000 | 1 | NIH | 12/27/2023 | $709,923 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS133226 | Central vs. Peripheral Mechanisms of Headache: Cortex, Thalamus, Dorsal Horn | 000 | 1 | NIH | 4/4/2024 | $419,283 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK135672 | Cav1.2 in bladder physiology and pathology | 000 | 1 | NIH | 3/21/2024 | $580,586 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK139434 | Targeted mRNA Delivery to Improve Diabetic Wound Healing | 000 | 1 | NIH | 2/21/2024 | $152,236 |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS133187 | Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease | 000 | 1 | NIH | 3/12/2024 | $665,971 |
|